logo
Book a meeting
Good Therapeutics

Good Therapeutics

Biotechnology, 1616 Eastlake Ave E, Seattle, Washington, 98102, United States, 11-50 Employees

goodtherapeutics.com

  • twitter
  • LinkedIn

Who is GOOD THERAPEUTICS

At Good Therapeutics we are developing protein-based drugs with regulated, context-dependent activity. Our new drugs can sense their local environment and respond by changing from an inac...

Read More

lock icon Get Full Access
map
  • 1616 Eastlake Ave E, Seattle, Washington, 98102, United States Headquarters: 1616 Eastlake Ave E, Seattle, Washington, 98102, United States
  • 2016 Date Founded: 2016
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GOOD THERAPEUTICS

Good Therapeutics Org Chart and Mapping

Employees
Alton Etheridge

Alton Etheridge

Scientist

See Full Org Chart arrow
email-formate-icon
View Email Formats for Good Therapeutics
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Good Therapeutics

Answer: Good Therapeutics's headquarters are located at 1616 Eastlake Ave E, Seattle, Washington, 98102, United States

Answer: Good Therapeutics's official website is https://goodtherapeutics.com

Answer: Good Therapeutics's revenue is $1 Billion and Over

Answer: Good Therapeutics's SIC: 2834

Answer: Good Therapeutics's NAICS: 325412

Answer: Good Therapeutics has 11-50 employees

Answer: Good Therapeutics is in Biotechnology

Answer: Good Therapeutics contact info: Phone number: Website: https://goodtherapeutics.com

Answer: At Good Therapeutics we are developing protein-based drugs with regulated, context-dependent activity. Our new drugs can sense their local environment and respond by changing from an inactive form to an active one. Unlike protease-activated therapeutics, the mechanism is reversible. The active form of the drug can change back to the inactive form when it is no longer in the presence of the activating signal. Our technology is based on allosteric control of protein activity a type of regulation that is widely found in nature but has yet to be applied to therapeutics.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access